Risk Factors for Treatment Drop-Out
Implications for Adverse Outcomes When Treating Opioid Use Disorder
Bibliographic Data
| ID | 15414074 |
|---|---|
| Authors | Patricia Ann Iovine (Northwell Health, corresponding author), David A Drachman (A.T. Still University), David Drachman (Adjunct Professor, College of Graduate Health Studies, AT Still University, Mesa, Arizona, USA), Harshal Kirane (Medical Director, Wellbridge Addiction Treatment and Research, Calverton, New York, USA) |
| Year | 2020 |
| Volume | 20 |
| Issue | 4 |
| Pages | 292-301 |
| Publication date | 2020-10-01 |
| Open Access | No |
| Type | ARTICLE |
| Venue | Journal of Social Work Practice in the Addictions (JOURNAL) |
| Journal identifiers | ISSN: 1533-256X • E-ISSN: 1533-2578 |
| Publisher | Taylor & Francis (PUBLISHER • GB) |
| DOI | 10.1080/1533256x.2020.1838859 |
| OpenAlex | W3107848732 |
| Language | EN |
| Citations received | 2 |
| References cited | 23 |
Pathways to resolve the opioid epidemic focus on enhancing addiction treatment. Dropout rates from outpatient buprenorphine-naloxone (BN) treatment remain as high as 35% to 59%, contributing to poor treatment outcomes. Treatment interventions targeting retention require identification of dropout risk factors. This study used the New York State Office of Alcohol and Substance Abuse Services database to analyze patient information from an ancillary withdrawal management program. Binary logistic regression identified dropout trends. Use of alprazolam or cocaine and age (< 26 years old) correlated with increased likelihood of treatment drop-out. In contrast, a history of domestic violence or intimate partner violence, alcohol use, or prior hospitalization for a psychiatric disorder (hospital stay < 30 days) were associated with an increased likelihood of retention. Potentially modifiable dropout risk factors exist in BN treatment. Recommendations for treatment programs using BN treatment are included
Addiction · Alcohol · Alcohol use disorder · Buprenorphine · Drop out · Dropout (neural networks · Drug · Heroin · Logistic regression · Opioid · Opioid use disorder · Psychiatry · Psychological intervention · Substance abuse · Clinical Psychology · Medicine · Opioid Use Disorder Treatment · Prenatal Substance Exposure Effects · Substance Abuse Treatment and Outcomes · Internal Medicine
| Citations per year | 1 |
|---|---|
| Citation span | 2024 - 2026 (3) |
| Highly cited | No |